佛羅里達 的 非小細胞肺癌 臨床試驗
155 項針對 非小細胞肺癌 的研究正在 佛羅里達 各地點尋找參與者。
佛羅里達 的城市
- Tampa51 項研究
- Orlando44 項研究
- Jacksonville39 項研究
- Miami31 項研究
- St. Petersburg21 項研究
- Sarasota17 項研究
- Plantation16 項研究
- Deltona15 項研究
- Coral Springs14 項研究
- West Palm Beach13 項研究
- Fort Lauderdale12 項研究
- Cape Coral12 項研究
- Gainesville10 項研究
- Hollywood10 項研究
- Ocala10 項研究
- Pembroke Pines8 項研究
- Largo6 項研究
- Port Saint Lucie5 項研究
- Clearwater5 項研究
- Miami Beach4 項研究
- Palm Bay4 項研究
- Boca Raton4 項研究
- Palm Coast4 項研究
- Davie4 項研究
- Lakeland4 項研究
- Port Charlotte3 項研究
- Tallahassee3 項研究
- Pensacola3 項研究
- Hialeah3 項研究
官方研究文本（英文）
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
- Holy Cross Hospital, Fort Lauderdale
- Regional Cancer Center-Lee Memorial Health System, Fort Myers
- 還有 6 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年10月2日 · NCT04267848A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
- The Oncology Institute of Hope and Innovation - Fort Lauderdale ( Site 0156), Fort Lauderdale
- Miami Cancer Institute at Baptist Health, Inc. ( Site 0214), Miami
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年10月2日 · NCT06623422Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
- Cancer Specialists of North Florida - Fleming Island, Fleming Island
- Cancer Specialists of North Florida - Riverside, Jacksonville
- Cancer Specialists of North Florida Southside, Jacksonville
- 還有 6 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年10月2日 · NCT06472245The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
- Advent Health, Orlando
- Florida Cancer Specialists South, Port Charlotte
招募中1/2 期
12 歲及以上 · 所有性別 · 更新於 2026年10月2日 · NCT04585750A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
- Florida Clinical Trials Group, Plantation
- Florida Clinical Trials Group - Tamarac, Tamarac
招募中2/3 期
18 歲及以上 · 所有性別 · 更新於 2026年10月2日 · NCT07365319Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
- Mayo Clinic in Florida, Jacksonville
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年10月2日 · NCT06265285Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #48, Celebration
- Exelixis Clinical Site #11, Gainesville
- Exelixis Clinical Site #78, Jacksonville
- 還有 2 項
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年10月1日 · NCT05176483A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- AdventHealth Medical Group Oncology Research at Celebration, Kissimmee
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年10月1日 · NCT06172478A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- Cancer Specialists of North Florida /ID# 277332, Jacksonville
- Cancer Care Centers of Brevard- Rockledge /ID# 277853, Rockledge
- Moffitt Cancer Center /ID# 276785, Tampa
招募中2/3 期
18 歲及以上 · 所有性別 · 更新於 2026年10月1日 · NCT07155187Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Moffitt Cancer Center, Tampa
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年10月1日 · NCT06625775Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- Morton Plant Hospital, Clearwater
- Miami Cancer Institute, Miami
- South Florida Baptist Hospital, Plant City
- 還有 6 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年10月1日 · NCT06498635A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
- Research Site, Jacksonville
招募中1/2 期
18 歲及以上 · 所有性別 · 更新於 2026年10月1日 · NCT06996782A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- ALX Center 7, Tampa
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年9月30日 · NCT07085091A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
- Local Institution - 0711, Ocala
- Local Institution - 0935, Plantation
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月30日 · NCT07361497A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
- Clermont Oncology Center, Clermont
- Advanced Research, Coral Springs
- BRP- Hialeah Hospital, Hialeah
- 還有 1 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月30日 · NCT07361510A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
- BRCR Global- Tamarac, Tamarac
- Moffit Cancer Centre, Tampa
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月30日 · NCT07659782Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
- Sylvester Comprehensive Cancer Center Miami, Miami
- AdventHealth Cancer Institute, Orlando
- H Lee Moffitt Cancer Center and Research Institute, Tampa
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月30日 · NCT06765109A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Research Site, Jacksonville
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年9月29日 · NCT05877599Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
- Mayo Clinic Hospital Jacksonville /ID# 275073, Jacksonville
- Mid Florida Hematology And Oncology Center /ID# 273777, Orange City
招募中1/2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月29日 · NCT06772623A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
- Florida Cancer Specialists & Research Institute - Sarasota Cattlemen, Sarasota
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年9月29日 · NCT07578571Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
- Florida Cancer Specialists & Research Institute - South, Fort Myers
- BRCR Global, Plantation
- Cancer Care Centers of Breevard, Rockledge
- 還有 3 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月29日 · NCT06881784A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
- Cancer Care Centers of Brevard, Inc., Palm Bay
- Florida Cancer Affiliates - Panama City, Panama City
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月28日 · NCT07144280A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
- Mount Sinai Medical Center, Miami Beach
- AdventHealth, Orlando
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月28日 · NCT05498428A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
- Mayo Clinic in Florida ( Site 0014), Jacksonville
- Mount Sinai Cancer Center ( Site 0038), Miami Beach
- Mid Florida Hematology and Oncology Center ( Site 0018), Orange City
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT06312137Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Florida Cancer Specialists, Bonita Springs
- Florida Cancer Specialists, Bradenton
- Florida Cancer Specialists, Cape Coral
- 還有 46 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT07222566A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Boca Raton Clinical Research Coral Springs, Coral Springs
- Florida Clinical Trials Group Plantation, Plantation
- Florida Clinical Trials Group Tamarac, Tamarac
招募中3 期
18 至 100 歲 · 所有性別 · 更新於 2026年9月25日 · NCT05920356Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
- Research Site, Jacksonville
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT06218914Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Mayo Clinic Jacksonville, Jacksonville
- Moffitt Cancer Center, Tampa
招募中觀察性研究
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT04981119This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
- Mid Florida Hematology and Oncology Center, Orange City
- BRCR Global, Plantation
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT06758401A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Baptist Lynn Cancer Institute, Boca Raton
- The Oncology Institute of Hope and Innovation 1, Fort Lauderdale
- Florida Cancer Specialists, Fort Myers
- 還有 12 項
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT06667076A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Mayo Clinic Jacksonville, Jacksonville
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT07154290A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
- University of Miami, Miami
- Orlando Health Cancer Institute, Orlando
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT06667908Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
- Mayo Clinic in Florida-Mayo Clinic Comprehensive Cancer Center ( Site 0133), Jacksonville
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT06170788Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
- BRCR Medical Center Inc., Coral Springs
- Mid Florida Hematology and Oncology Center, Orange City
- Orlando Health Ambulatory Care Center, Orlando
- 還有 3 項
招募中1/2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT07227298A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
- Research Site, Bay Pines
- Research Site, Clearwater
- Research Site, Gainesville
- 還有 1 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT06868277Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
- Boca Raton Regional Hospital, Boca Raton
- Florida Cancer Specialists - South, Fort Myers
- Miami Cancer Institute at Baptist Health, Inc., Miami
- 還有 5 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月24日 · NCT06890598Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- MDR Core Network, Boynton Beach
招募中1/2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月24日 · NCT06047379Pan-tumor MRD Study
- Oncology & Hematology Associates of West Broward, Coral Springs
- Mid Florida Cancer Centers, Orange City
- Comprehensive Hematology Oncology (CHO), St. Petersburg
招募中觀察性研究
18 歲及以上 · 所有性別 · 更新於 2026年9月24日 · NCT06605404Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- Holy Cross Hospital, Fort Lauderdale
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月24日 · NCT03191149A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
- Memorial Hospital West, Pembroke Pines
- Florida Cancer Specialists - North, St. Petersburg
- Florida Clinical Trials Group., Tamarac
- 還有 1 項
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月23日 · NCT06561386資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。